Literature DB >> 20118407

Calcium-independent phospholipase A(2) plays a key role in the endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

Michael S K Wong1, Ricky Y K Man, Paul M Vanhoutte.   

Abstract

Phospholipase A(2) (PLA(2)), a regulatory enzyme found in most mammalian cells, catalyzes the breakdown of membrane phospholipids to arachidonic acid. There are two major cytosolic types of the enzyme, calcium-dependent (cPLA(2)) and calcium-independent (iPLA(2)) PLA(2). The present study investigated whether or not iPLA(2) plays a role in the endothelium-dependent contractions of the aorta of the spontaneously hypertensive rat and its normotensive counterpart, the Wistar-Kyoto rat. The presence of iPLA(2) in the endothelial cells was identified by using immunochemistry and immunoblotting. Aortic rings with and without the endothelium were suspended in organ chambers for isometric tension recording. The production of prostanoids was measured by using enzyme immunoassay kits. iPLA(2) was densely distributed in endothelial cells of the aorta of both strains. At 3 x 10(-6) M, the selective iPLA(2) inhibitor, bromoenol lactone (BEL), abrogated endothelium-dependent contractions induced by acetylcholine but not those evoked by the calcium ionophore A-23187. The effects of BEL were similar in the aortae of Wistar-Kyoto and spontaneously hypertensive rats. The nonselective PLA(2) inhibitor quinacrine abolished the contractions triggered by both acetylcholine and A-23187, whereas the store-operated calcium channel inhibitor SKF-96365 prevented only the acetylcholine-induced contraction. The acetylcholine- but not the A-23187-induced release of 6-keto prostaglandin F(1alpha) was inhibited by BEL. The release of thromboxane B(2) by either acetylcholine or A-23187 was not affected by BEL. In conclusion, iPLA(2) plays a substantial role in the generation of endothelium-derived contracting factor evoked by acetylcholine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118407     DOI: 10.1152/ajpheart.01068.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  17 in total

Review 1.  Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets.

Authors:  Michel Félétou; Ralf Köhler; Paul M Vanhoutte
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 2.  Vasoconstrictor prostanoids.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-24       Impact factor: 3.657

3.  Non-steroidal anti-inflammatory drugs attenuate the vascular responses in aging metabolic syndrome rats.

Authors:  María Esther Rubio-Ruiz; Israel Pérez-Torres; Eulises Diaz-Diaz; Natalia Pavón; Verónica Guarner-Lans
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

Review 4.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

5.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

6.  Deletion of T-type calcium channels Cav3.1 or Cav3.2 attenuates endothelial dysfunction in aging mice.

Authors:  Anne D Thuesen; Kenneth Andersen; Kristina S Lyngsø; Mark Burton; Charlotte Brasch-Andersen; Paul M Vanhoutte; Pernille B L Hansen
Journal:  Pflugers Arch       Date:  2017-10-29       Impact factor: 3.657

7.  Bromoenol lactone inhibits voltage-gated Ca2+ and transient receptor potential canonical channels.

Authors:  Saikat Chakraborty; Zachary C Berwick; Paula J Bartlett; Sanjay Kumar; Andrew P Thomas; Michael Sturek; Johnathan D Tune; Alexander G Obukhov
Journal:  J Pharmacol Exp Ther       Date:  2011-07-27       Impact factor: 4.030

8.  Amplification of the COX/TXS/TP receptor pathway enhances uridine diphosphate-induced contraction by advanced glycation end products in rat carotid arteries.

Authors:  Takayuki Matsumoto; Mihoka Kojima; Keisuke Takayanagi; Tomoki Katome; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2019-11-18       Impact factor: 3.657

9.  Chronic social isolation in the prairie vole induces endothelial dysfunction: implications for depression and cardiovascular disease.

Authors:  Jacob D Peuler; Melissa-Ann L Scotti; Laura E Phelps; Neal McNeal; Angela J Grippo
Journal:  Physiol Behav       Date:  2012-03-26

Review 10.  Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.